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Abstract: High-throughput sequencing of the B cell receptor (BCR) repertoire can provide rapid char-
acterization of the B cell response in a wide variety of applications in health, after vaccination and in
infectious, inflammatory and immune-driven disease, and is starting to yield clinical applications. How-
ever, the interpretation of repertoire data is compromised by a lack of studies to assess the intra and
inter-individual variation in the BCR repertoire over time in healthy individuals. We applied a stan-
dardized isotype-specific BCR repertoire deep sequencing protocol to a single highly sampled participant,
and then evaluated the method in 9 further participants to comprehensively describe such variation. We
assessed total repertoire metrics of mutation, diversity, VJ gene usage and isotype subclass usage as
well as tracking specific BCR sequence clusters. There was good assay reproducibility (both in PCR
amplification and biological replicates), but we detected striking fluctuations in the repertoire over time
that we hypothesize may be due to subclinical immune activation. Repertoire properties were unique for
each individual, which could partly be explained by a decrease in IgG2 with age, and genetic differences
at the immunoglobulin locus. There was a small repertoire of public clusters (0.5, 0.3, and 1.4% of total
IgA, IgG, and IgM clusters, respectively), which was enriched for expanded clusters containing sequences
with suspected specificity toward antigens that should have been historically encountered by all partic-
ipants through prior immunization or infection. We thus provide baseline BCR repertoire information
that can be used to inform future study design, and aid in interpretation of results from these studies.
Furthermore, our results indicate that BCR repertoire studies could be used to track changes in the
public repertoire in and between populations that might relate to population immunity against infectious
diseases, and identify the characteristics of inflammatory and immunological diseases.
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High-throughput sequencing of the B cell receptor (BCR) repertoire can provide rapid 
characterization of the B cell response in a wide variety of applications in health, after 
vaccination and in infectious, inflammatory and immune-driven disease, and is starting 
to yield clinical applications. However, the interpretation of repertoire data is compro-
mised by a lack of studies to assess the intra and inter-individual variation in the BCR 
repertoire over time in healthy individuals. We applied a standardized isotype-specific 
BCR repertoire deep sequencing protocol to a single highly sampled participant, and 
then evaluated the method in 9 further participants to comprehensively describe such 
variation. We assessed total repertoire metrics of mutation, diversity, VJ gene usage 
and isotype subclass usage as well as tracking specific BCR sequence clusters. There 
was good assay reproducibility (both in PCR amplification and biological replicates), 
but we detected striking fluctuations in the repertoire over time that we hypothesize 
may be due to subclinical immune activation. Repertoire properties were unique for 
each individual, which could partly be explained by a decrease in IgG2 with age, and 
genetic differences at the immunoglobulin locus. There was a small repertoire of public 
clusters (0.5, 0.3, and 1.4% of total IgA, IgG, and IgM clusters, respectively), which was 
enriched for expanded clusters containing sequences with suspected specificity toward 
antigens that should have been historically encountered by all participants through prior 
immunization or infection. We thus provide baseline BCR repertoire information that can 
be used to inform future study design, and aid in interpretation of results from these 
studies. Furthermore, our results indicate that BCR repertoire studies could be used 
to track changes in the public repertoire in and between populations that might relate 
to population immunity against infectious diseases, and identify the characteristics of 
inflammatory and immunological diseases.
Keywords: B cell, antibody diversity, immunoglobulin repertoire, B cell receptor repertoire, VDJ recombination, 
genetic variation, immunoglobulin gene, reproducibility
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inTrODUcTiOn
An effective humoral immune response is in part dependent on 
having a diversity of B cells with different B cell receptors (BCRs) 
capable of recognizing and binding to many different antigens. 
The sum of all B cells with distinct BCRs is termed the BCR 
repertoire, and in humans has the theoretical potential to reach 
a size of up to 1011 unique variants (1). BCRs consist of paired 
heavy and light chains, with primary diversity generated by the 
somatic recombination of V, D (heavy chain only), and J gene 
segments during B cell development to form the functional genes 
(2). Further diversity is introduced by the random addition and 
deletion of nucleotides at the junctions of the gene segments. 
Upon B cell activation and proliferation, there is a secondary 
diversification step mediated by somatic hypermutation, and 
selection of B cells with increasing affinity for the antigen (3). 
Although the BCR repertoire is often considered as a single entity, 
it is actually a mixture of different B cell subpopulations, each of 
which may have a distinct repertoire structure (4, 5).
The vast diversity of the BCR repertoire has made it difficult 
to study, but next-generation sequencing (NGS) technology now 
makes it possible to capture a high-resolution snapshot of the 
circulating BCR repertoire in humans. Obtaining information 
on paired heavy and light chains is technically challenging (6), so 
studies of the BCR repertoire generally focus on the heavy chain, 
which is the most variable, and most important for determining 
antigen-binding specificity (7). BCR repertoire analysis has been 
used to increase understanding of the fundamental properties of 
B cells, including developmental processes (8), and responses to 
antigen (4, 9–13). In addition, a number of clinical applications 
are beginning to emerge, including identification of autoimmune 
irregularities (14), monitoring of B cell lymphoma minimal 
disease residue (15, 16), disease diagnostics (17), and the rapid 
identification of monoclonal antibody sequences (18). These 
studies generally monitor global features of the BCR repertoire, 
such as diversity, mutation levels, isotype subclass usage, and 
VDJ segment usage frequency as well as identifying specific B 
cell clones. Identifying B cells arising from the same clonal origin 
was initially conducted based on identifying common VDJ seg-
ment usage (15), but there is now a move toward incorporating 
complementarity-determining region (CDR) three amino acid 
(AA) sequence identity into the definition (8, 17), which forms at 
the junction of VDJ joining and is the most important region for 
determining antigen-binding properties (19).
B cell samples for repertoire studies in humans are usually 
obtained from peripheral blood as this is an easy to sample 
compartment, but it is not possible to extract all peripheral 
blood from humans, and some B cells may be present in differ-
ent compartments. This means that the entire repertoire cannot 
be sampled, so instead a representative sample is taken. It is, 
therefore, important to quantify exactly what proportion of the 
repertoire is being sampled, and how repeatable the sampling is. 
This is particularly pertinent for clinical applications where it is 
necessary to have a highly repeatable measure to detect the clones 
of interest. As BCR repertoire sequencing is a young technology, 
such repeatability studies have been done in mice (20), but not 
exhaustively in humans, who have a much larger repertoire 
(1). Many studies of the BCR repertoire also assess changes in 
various features of the repertoire over time in response to certain 
interventions (9, 11–13). However, there is relatively little known 
about how the much the repertoire naturally fluctuates over time 
in the absence of any specific intervention, making it difficult 
to discern natural fluctuations from intervention-induced fluc-
tuations. Furthermore, as the total number of healthy individuals 
who have had their repertoire sequenced remains small, there is 
not a clear consensus of what can be construed as a “normal” 
repertoire. It is uncertain to what extent similar B cell clones 
can be found in multiple individuals (the public repertoire) not 
undergoing a similar immune stimulus, and whether sharing is 
just due to chance, or due to historic expansion of similar B cells 
in different individuals from a common antigen and thus have 
some clinical significance (4, 11, 17, 21).
We sought to shed light on these questions by carrying out 
repeat sampling from a single individual to assess the robustness 
of a BCR repertoire sequencing protocol, and also to determine 
how the repertoire changed over time in the absence of any 
intervention (Figure  1). Furthermore, sequencing of the BCR 
repertoire from nine additional individuals was conducted to 
determine how variable the repertoire was between them, and to 
interrogate properties of the public repertoire.
MaTerials anD MeThODs
sample collection
Subjects were recruited with informed consent in accordance 
with the Declaration of Helsinki, and under approval from the 
Northampton Research Ethics Committee (13/EM/0036). For 
the assessment of inter-individual variation, 10 participants had 
blood sampled at a single timepoint. In addition, to assess within-
individual variation, and repeatability of the protocol, there was 
a single highly sampled participant, who had blood sampled on 
five consecutive weeks (days 0, 7, 14, 21, and 28) to give temporal 
replicates (Figure 1). Blood was transferred to a heparinized tube 
for processing within 4 h of collection.
B cell isolation
PBMC’s were first isolated from heparinized blood by 
density-gradient centrifugation over lymphoprep (Axis-Shield 
Diagnostics). Magnetic-activated cell sorting was then used to 
isolate B cells, using the AutoMACS Pro cell separator (Miltenyi 
Biotec), and CD19+ microbead kit. B cells were counted using a 
hemocytometer (Neubauer), and split into aliquots each contain-
ing 500,000 cells. Sorted B cells were resuspended in RLT buffer 
(Qiagen) and frozen at −80°C prior to repertoire sequencing. 
For each participant, a single 500,000 B cell aliquot was used for 
repertoire sequencing. An additional 500,000 B cell aliquot was 
also taken for the highly sampled participant to give biological 
replicates.
repertoire sequencing
RNA was extracted from sorted cells using the RNeasy Mini Kit 
(Qiagen), and reverse transcription performed using SuperScript 
III (Invitrogen), and random hexamer primers (42°C for 60 min, 
October 2015 | Volume 6 | Article 5313
Galson et al. Within and inter-individual variation in the BCR repertoire
Frontiers in Immunology | www.frontiersin.org
95°C for 10 min). BCR heavy chain genes were amplified using 
the Multiplex PCR kit (Qiagen) with V family specific forward 
primers, and in separate reactions with either IgA, IgG, or IgM 
specific reverse primers (22) (94°C for 15 min, 30 cycles of 94°C 
for 30 s, 58°C for 90 s and 72°C for 30 s, and 72°C for 10 min). 
For the biological replicates, only IgG reactions were performed, 
but for all other samples, IgA, IgG, and IgM reactions were all 
carried out. In addition, for one of the aliquots at each timepoint 
from the highly sampled participant, the IgG PCR was repeated 
to give PCR replicates. PCR amplicons were gel-extracted, 
purified, and quantified using a Qubit fluorometer (Invitrogen). 
Samples were then A-tailed and adaptor ligated prior to size 
selection and amplification for sequencing on the MiSeq using 
the 2 × 300 bp paired-end chemistry (Illumina). Samples were 
multiplexed in batches of 50 for sequencing, and indexed using 
the Illumina tags.
raw sequence Processing
Paired-end reads were joined to give a continuous sequence 
spanning from framework region 1 to within the constant region 
using fastq-join (ea-utils), and default settings. Initial quality 
filtering was performed to remove any sequences containing 
unknown nucleotides, or with a Phred quality <30 over more 
than 15% of bases. Sequences were then submitted to IMGT/
HighV-Quest (23) for annotation, and unproductive sequences 
(as defined by IMGT) removed. To account for differences in 
the number of resulting sequences in different samples, all 
samples were randomly subsampled without replacement 
using the sample function in R (24) to give 100,000 sequences 
per sample.
FigUre 1 | sampling scheme. For assessment of within-individual variation, one participant (participant AF01) had blood sampled at five timepoints 1 week apart 
(temporal replicates). For this participant, two aliquots of B cells were taken at each timepoint to give biological replicates. IgA, IgG, and IgM isotype-specific PCRs 
were all conducted for one of the biological replicates, but only IgG for the second biological replicate (IgG 3). Additionally, for this participant, IgG PCR replicates 
were also conducted at each timepoint for one of the biological replicates (IgG 2). For assessment of inter-individual variation, nine additional participants were 
sampled at a single timepoint, and had IgA, IgG, and IgM PCRs conducted.
sequence-level annotation
Germline V and J gene usage, CDR3 AA sequence, number of V 
gene mutations from germline, and constant region nucleotide 
sequence was determined for each sequence by IMGT. Constant 
region sequences were then mapped to germline using Stampy 
(25) to determine isotype subclass, and number of nucleotide 
mismatches. Number of nucleotide mismatches in the constant 
region was used for error rate estimation, as this region will not be 
subject to somatic hypermutation. For each CDR3 AA sequence, 
the distance to its nearest neighbor in the same sample was deter-
mined. The nearest neighbor was defined as the sequence with 
the same CDR3 AA length and the fewest mismatches, with the 
nearest neighbor distance being the count of these mismatches.
cluster-level annotation
Clustering was performed using a previously described method 
(4), to form groups of sequences which are sufficiently similar 
that they are likely to be clonally related, or differ due to PCR 
and sequencing error. To be considered part of the same cluster, 
sequences were required to have the same length CDR3, the 
same V and J gene annotation, and a similar CDR3 AA sequence. 
Different thresholds for CDR3 similarity were trialed, ranging 
from one AA mismatch allowed per four AA’s (≥75% similarity) 
to one AA mismatch per 26 AA’s (≥96% similarity). D gene anno-
tation was not considered, as this can not be carried out with a 
high degree of certainty (26), and the underlying D gene sequence 
is anyway included in the CDR3 AA sequence. Sequences from 
all samples were clustered together to allow easy comparison of 
clusters between participants and over time. The number of par-
ticipants each cluster was present in was determined, along with 
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specific comparisons of clusters present in different replicates. 
Each cluster was annotated with its dominant “cluster center” 
CDR3 AA sequence, the total number of unique sequences 
within it from a particular sample, in addition to the mean V 
gene mutation of these sequences, and their isotype subclass 
usage. Nearest neighbor distances were also calculated for cluster 
center sequences in the same way they were calculated for the 
individual sequences. Clusters were annotated for having poten-
tial binding specificity toward either influenza or tetanus toxoid 
(TT) antigens based on comparison to previously published 
sequences known to be specific for these antigens (27–34). The 
comparison of clusters to these known sequences was based on 
CDR3 AA sequence identity only, and was based on whether the 
known sequence would have fallen into that cluster during the 
clustering process (i.e., allowing one AA mismatch per 12 AAs).
repertoire-level annotation
The mean CDR3 AA length, and number of V gene mutations 
were calculated for each sample using all sequences in the 
repertoire. In addition, the relative proportion of the repertoire 
comprised by sequences using different V and J genes (and VJ 
combinations), and of different isotype subclasses was calculated 
for each sample.
Repertoire diversity was calculated using three different 
single diversity metrics, which have previously been applied to 
repertoire studies. The Shannon entropy index and Simpson’s 
concentration index are derived from ecology and take into 
account species richness and abundance in a single sample; 
for the purpose of studying the BCR repertoire, each cluster is 
considered a distinct species. The Shannon index gives more 
weight to rare species while the Simpson index gives more weight 
to abundant species. In addition, a clonality index derived from 
cryptanalysis (the study of text-based ciphers) was used which 
measures the probability that sequences selected from different 
PCR replicate samples belong to the same cluster (35). As well as 
these single diversity indices, Hill-based diversity profiles of each 
repertoire were generated using the method described by Greiff 
et al. (36). These profiles are based on a continuum of diversity 
measures with different weighting (alpha values) ascribed to the 
abundant and rare species. Alpha values between 0 and 10 were 
used with a step value of 0.5.
statistical analysis and graphing
Statistical analysis was conducted in R (24), using ggplot2 (37) 
for constructing graphs, gplots for constructing heatmaps (38), 
and Circos (39) used for constructing circular plots. Rarefaction 
analysis was conducted using the Vegan R package (40), with 
individual clusters representing species, and sampling done 
without replacement. Extrapolation of the rarefaction curves 
was conducted based on Chao’s estimates (41), using the iNEXT 
package in R (42) with a q value of 0. Simpson’s concentration, 
Shannon entropy, and diversity profiles were all calculated using 
the Vegan R package (40). Diversity profiles were compared 
based on Euclidean distance and clustered using the complete 
linkage algorithm with the hclust function in the Stats R pack-
age (24). Principal component analysis was conducted using the 
prcomp R function in the Stats R package (24). Capture-recapture 
analysis was used to estimate the effective repertoire size using 
the Chapman-Estimator formula, which has previously been 
applied to BCR repertoires (43). Genotyping was carried out 
using TIgGER (44).
resUlTs
sequencing Output and clustering
Repertoire data were successfully obtained for all 52 samples 
(Table S1 in Supplementary Material). The mean number of raw 
sequences per sample was 367,634 (216,878–1,516,275). Quality 
filtering removed on average 31% of raw sequences, leaving at 
least 100,000 sequences per sample for subsequent analysis. 
Error rate estimates differed depending on the isotype of the 
sequence, and were 0.0021, 0.0079, and 0.0019 errors per nucleo-
tide for IgA, IgG, and IgM sequences, respectively (Figure S1 in 
Supplementary Material). To mitigate the effect of the error on 
subsequent analyses, data were clustered to group together closely 
related sequences. Analyzing the AA distance between CDR3 
sequences prior to clustering revealed a bimodal distribution: the 
first peak of sequences had a close neighbor 0–2 AAs away, and 
the second peak of sequences had a more distant neighbor 3–15 
AAs away (Figure 2A). The first peak was higher for IgA and IgG 
compared to IgM sequences, and the position of the second peak 
was shifted 1 AA toward the y-axis for the IgM sequences. As 
the first peak likely contains sequences whose nearest neighbor is 
either clonally related or differs due to error and the second peak 
likely contains sequences whose nearest neighbor arises from a 
distinct B cell clone, clustering should ensure that sequences with 
a neighbor in the first peak are clustered together, but sequences 
with a neighbor in the second peak are not. To find the clustering 
threshold that best achieved this, different thresholds allowing 
between one AA mismatch per every four AA’s to one AA mis-
match per every 26 AA’s (i.e., from ≥75% to ≥96% similarity) in 
the CDR3 AA sequence were trialed. Above a threshold of one AA 
mismatch per 12 AA’s there is a failure to cluster some sequences 
differing by two AA’s (Figure S2A in Supplementary Material), 
and below a threshold of one AA mismatch per eight AA’s, there 
is a sharp drop in the number of clusters formed (Figure S2B in 
Supplementary Material), indicating that sequences from unre-
lated cells start to be grouped. A threshold of one AA mismatch 
per 12 AA’s was, therefore, chosen for the final analysis; however, 
it should be noted that using a threshold anywhere between one 
AA mismatch per eight AA’s and one AA mismatch per 12 AA’s 
gave negligible difference to the conclusions presented here.
Following final clustering with the threshold of one AA mis-
match per 12 AA’s, the mean number of clusters differed for the 
different isotypes, and was 9,972 for IgA (1,658–22,940), 15,080 
for IgG (1,599–25,000), and 53,150 for IgM (19,000–75,420) 
(Table S1 in Supplementary Material). Following clustering, the 
amplitude of the first peak of the nearest neighbor distribution of 
cluster center CDR3 AA sequences was greatly reduced for IgA 
and IgG sequences, and completely removed for IgM sequences 
(Figure  2B). Cluster sequences with a distance of 0 to their 
neighbor represent clusters with the same CDR3, but different 
V and/or J gene annotations. Although such sequences could be 
FigUre 2 | effect of clustering on the dataset. Nearest neighbor 
distributions of sequences both before (a) and after (B) clustering. Before 
clustering, CDR3 AA sequences are used, and after clustering, the cluster 
center AA sequence is used. The nearest neighbor of each sequence in each 
dataset is determined by comparing it to every other sequence of the same 
length in the dataset to find the closest match – that is its nearest neighbor. 
The distance is then the number of AA difference between the sequence and 
its nearest neighbor. Distributions were calculated from samples from all 10 
participants, and mean ± SEM values plotted. (c) Clusters are ordered 
according to size, and the size of each cluster plotted. Representative data 
from one sample is shown (participant AF01, day 0). Horizontal dotted line 
intersects the y-axis at 10 sequences (0.01% of the total sequenced 
repertoire), and represents the cutoff between rare and abundant clusters.
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chimeras formed during the PCR reaction, they are not present in 
the IgM dataset, making this unlikely, and were, thus, retained for 
analysis; it has also previously been reported that such sequences 
can form during convergent evolution in response to antigen (12). 
The size distribution of clusters was highly uneven, with a small 
number of abundant clusters, and a large number of rare clusters 
(Figure  2C). Based on this, we defined clusters as abundant if 
they contained at least 10 sequences (i.e., comprised at least 0.01% 
of the total sequenced repertoire). Datasets contained mean 930 
(518–1,537), 835 (195–1,983), and 642 (195–1,983) abundant 
clusters for IgA, IgG, and IgM, respectively.
Quantitative assessment of  
sequencing Depth
Two methods were used to assess the adequacy of the sequencing 
depth used: rarefaction analysis, and comparison of the PCR 
replicates. Rarefaction is a technique used in ecology to estimate 
species richness; in the context of the BCR repertoire, each cluster 
is defined as a unique species. Random samples of increasing size 
were taken from the total dataset to determine the number of 
clusters that were represented at increasing sequencing depths, 
and a curve was drawn to show the number of clusters represented 
as a function of sequencing depth (Figure  3A). As the curve 
plateaus, it indicates that sequencing depth is sufficient, and only 
the very rare clusters remain to be identified. The curves for IgA 
and IgG do show the beginning of a plateau, so we can infer that 
a sequencing depth of 100,000 is sufficient to capture most of the 
abundant clusters for these samples. For IgM samples, which had 
a much larger number of rare clusters (Figure 2C), the curve does 
not begin to plateau, so we are unlikely to be capturing the full 
diversity of this population. If the curve does not plateau, it can 
be extrapolated to estimate where the plateau would occur, and 
give an estimate of the effective population size (a lower bound 
for the total number of clusters) of the population. However, these 
extrapolated values should be treated as rough values only, as they 
assume that all clusters will be present at the same frequency, and 
become unreliable once extrapolated to twice the interpolated 
number (41). Using the extrapolated curves to estimate total 
number of clusters for the different samples gives a mean value 
of 15,414 total clusters for IgA, 19,488 for IgG, and 143,731 for 
IgM, indicating that our sequencing depth captures ~63, 64, and 
36% of all IgA, IgG, and IgM clusters, respectively. In order to 
capture 90% of clusters contained in a sample of 500,000 B cells, 
it would, therefore, be necessary to obtain ~280,000 sequences for 
IgA, 260,000 for IgG, and 620,000 for IgM.
PCR replicates were only conducted for IgG samples, so 
comparison of these can only be used to assess sequencing depth 
for this isotype. Although simply re-sequencing the same library 
can also be used to assess sequencing depth, conducting the PCR 
again prior to sequencing is a more stringent measure that will 
also take into account differences in amplification efficiency of 
the template cDNA. Across the five samples where PCR replicates 
were available, the mean overlap of clusters present in both PCR 
replicates was 58%, but this increased to 95% when just consider-
ing the abundant clusters (Figure 3B; Figure S3 in Supplementary 
Material). In addition to identification of specific sequences, 
many repertoire studies also assess relative proportions of differ-
ent VJ combinations. To determine the reproducibility of this, the 
proportional representation of each VJ clone in the repertoire was 
determined for each sample, and correlated. Strong correlations 
were seen, with Pearson’s r > 0.997 for all PCR replicate samples 
(Figure 3C).
Quantitative assessment  
of sampling Depth
To assess the adequacy of sampling 500,000 B cells for assessment 
of the total BCR repertoire, we used the biological replicates to 
estimate a lower bound for the total IgG BCR cluster repertoire 
size using capture-recapture analysis. Across the five samples 
where biological replicates were available, the mean IgG effective 
repertoire size was estimated as 142,576 unique clusters; as we 
obtained a mean of 15,128 total IgG clusters from these samples, 
we estimate that ~11% of the total repertoire was sampled at each 
timepoint (Table 1). Taking just the abundant clusters, the mean 
estimated BCR repertoire size of abundant clusters was 4,644, 
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indicating that we sample ~25% of the abundant repertoire at 
each timepoint. Estimates of repertoire size varied on the dif-
ferent days of sampling, and this variation in size estimates was 
more pronounced for the abundant repertoire (up to 8.9× size 
difference between days) compared to the total repertoire (up to 
1.5× size difference between days).
As with the PCR replicates, the overlap in clusters present in 
both of the biological replicates was also calculated (Figure 3D; 
FigUre 3 | assessment of sequencing and sampling depth. (a) 
Extrapolated rarefaction curves for clusters of each isotype. Rarefaction 
analysis (interpolated) was conducted by subsampling data without 
replacement at 1,000 sequence increments, and determining the number of 
clusters represented by these sequences. Cluster richness estimation of the 
sample (extrapolation) was based on Chao’s estimator formula, and 
conducted up to a sequencing depth of 500,000 sequences. The curve 
shows the number of clusters identified as a function of sampling depth – as 
the curves start to plateau it indicates that increased sampling depth will yield 
few additional clusters, and sampling depth is sufficient. Results were 
calculated from samples from all 10 participants, and mean ± SEM (gray 
curve) plotted. The three horizontal gray lines show the mean ± SEM for the 
Chao estimate of total clusters in the sample. (B) For the PCR replicates, the 
percent of clusters present in both replicates was determined, where 
percent = (A∩B/min(A,B)) × 100. This was determined for total clusters, rare 
clusters (<10 sequences), and abundant clusters (≥10 sequences) for all 10 
participants, and mean ± SEM values plotted. (c) Correlation in proportion of 
the total repertoire comprised by each VJ gene combination in the two PCR 
replicates at each day. Each point represents the proportional representation 
of a particular VJ combination in the repertoire. r-Values represent Pearson’s 
correlation coefficients. (D,e) Same as (B,c), but comparing the biological 
replicates.
Figure S3 in Supplementary Material). The mean overlap of total 
clusters present in both biological replicates was 14%, although 
this increased to 44% when considering the abundant clusters only. 
The reproducibility of VJ usage frequency remained strongly cor-
related between the biological replicates, with Pearson’s r > 0.995 
for all samples (Figure 3E).
Fluctuations in the repertoire over Time
For a single participant, individual clusters were tracked across 
the samples collected at different times to see if they could be 
detected on multiple days. Although most clusters were present 
on just a single day, 5, 14, and 7% were detected on more than 
1 day for IgA, IgG, and IgM, respectively (Figure 4A). In addition, 
there were a small number of clusters detected at all timepoints. 
Circos plots were constructed to show the relationship between 
the clusters present on different days, and show that it is primar-
ily the abundant clusters that are present on more than 1  day 
(Figure 4B).
In addition to monitoring individual clusters, global repertoire 
metrics of VJ segment usage (Figure 5A), mutation (Figure 5B), 
diversity (Figure  5C), and isotype subclass (Figure  5D) were 
determined at each day. Different single measurements for 
diversity were used, but they all gave the same trend (Figure S4 in 
Supplementary Material). Although most clusters do not persist 
over time, VJ segment usage frequency remained highly cor-
related between all days. Although the other repertoire metrics 
were highly conserved between both the PCR and biological 
replicates, on day 7, there was a large fluctuation in the reper-
toire, causing an increase in mutation and a decrease in diversity 
(most prominently in the IgG datasets), and a relative decrease 
in IgG1, and increase in IgG3 usage. Although there were actu-
ally fewer abundant clusters on day 7 than on the other days, 
the size of these abundant clusters tended to be greater (Figure 
S5 in Supplementary Material), suggestive of clonal expansions 
occurring at this timepoint. The use of diversity profiles has 
recently been reported as a more accurate method for determin-
ing immunological status from BCR data than the use of single 
diversity measures (36), and these results are shown in Figure 5E. 
The difference between the diversity profiles of different samples 
can then be calculated, and used for hierarchical clustering of the 
samples based on diversity. This revealed that all day 7 samples 
clustered together regardless of isotype. All IgM samples also 
clustered together, but the distinction between IgA and IgG 
samples was not as clear.
inter-individual Variation in the repertoire
As well as the single highly sampled participant, nine additional 
participants were sampled at a single timepoint to give insight 
into inter-individual variation in the repertoire. Although at the 
cluster level, there was very little overlap between the repertoires 
of different participants (Figure S3 in Supplementary Material), 
the repertoires of different participants were more comparable 
at the level of the general repertoire properties. Different V and 
J gene segments are not used in even proportions, and these 
biases in gene use are conserved between different participants 
(Figure S6 in Supplementary Material). To more specifically 
TaBle 1 | number of total clusters, and abundant clusters for the igg 1 sample at each timepoint from participant aF01, size estimates of the total igg 
and abundant igg cluster repertoire based on capture-recapture analysis of biological replicates, and the percent of the total repertoire, and abundant 
repertoire that we sequenced.




Total clusters  
size estimate






0 12,152 1,919 132,841 10,426 9.1 18.4
7 13,186 367 108,253 1,168 12.2 31.4
14 16,907 1,137 162,868 5,368 10.4 21.2
21 17,930 861 158,311 3,013 11.3 28.6
28 15,463 775 150,605 3,245 10.3 23.9
Mean 15,128 1,012 142,576 4,644 10.7 24.7
FigUre 4 | Persistence of clusters over time. (a) For samples of each 
isotype from participant AF01, the total number of clusters across all 
timepoints was determined, and the number of these present at different 
number of timepoints calculated. (B) Using the same data as A, circos plots 
were constructed to show the clusters present on different days. Each arc 
represents a different day, and clusters are ordered clockwise by abundance, 
with the abundant clusters colored orange, and the rare clusters colored 
blue. Lines join clusters present at more than one timepoint.
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assess any differences in VJ usage between participants, principle 
component analysis was used. This is a dimensional reduction 
technique that takes into account independent correlations in 
usage frequencies between variables (VJ combinations) to give 
components that can explain the largest proportion of the total 
variability in the data. The first two principle components account 
for the largest proportion of variability, and in the case of VJ 
usage, account for ~40% of the variability. Plotting the samples 
according to the first two principle components shows that the 
samples from different participants cluster apart from each other 
compared to the samples on different days from participant AF01 
which cluster closely together, indicating that VJ usage frequency 
is able to uniquely identify the different participants, and remains 
steady in participant AF01 despite apparent immune activation 
(Figure 6A). Furthermore, the V gene genotype was inferred for 
each participant, indicating that each participant had a unique V 
gene genotype (Table S2 in Supplementary Material). Ten puta-
tive novel alleles were also found, that were not contained within 
the IMGT database; two of these have previously been reported, 
giving good evidence for them being real alleles (44).
The global repertoire properties of mutation (Figure  6B), 
diversity (Figure  6C), and isotype subclass usage (Figure  6D) 
were also determined for each participant. There was considerable 
variation in each of these properties between the participants. 
Participant 1368 appeared to consistently be an outlier in nearly 
all measures for all isotypes, and notably for IgG had a highly 
mutated repertoire with low diversity, which is indicative of clonal 
expansions. The study was not powered to detect age-related dif-
ferences in the repertoire, but we had an even mix of participants 
between the ages of 22 and 59. We correlated each of the global 
repertoire properties with age, and found a significant decrease in 
IgG2 usage with age, giving a relative increase in IgG1 and IgG3 
use (Figure S7 in Supplementary Material). Although not signifi-
cant, other global repertoire metrics also appeared to change with 
age (increase in mutation, and decrease in diversity with age), and 
warrant exploration with appropriately powered studies.
The Public repertoire
The public repertoire is defined as set of clusters within the 
repertoire that are common to multiple participants, whereas 
the private repertoire is the set of clusters that are unique to a 
particular participant. In an unstimulated setting, the public 
repertoire comprises a very minor part of the total repertoire, but 
is greater for IgM than IgG or IgA (1.4, 0.3, and 0.5% of total clus-
ters, respectively). Considering the number of clusters present in 
different numbers of participants, there was a sharp reduction 
when considering clusters shared by increasing numbers of 
participants, and there was only a single cluster (IgM) that was 
present in all participants (Figure 7A). Compared to the private 
repertoire, the public repertoire comprised larger clusters that had 
shorter CDR3’s (Figures 7B,D). For IgG, the public clusters were 
more mutated than the private clusters, but for IgM, the public 
clusters were actually less mutated than the private clusters, with 
no significant difference for IgA (Figure 7C).
Comparing previously described sequences specific for TT or 
influenza to out dataset revealed 50 TT-specific (of 1,093), and 19 
influenza-specific (of 321) sequences that mapped to clusters in 
our dataset (Table S3 in Supplementary Material). These clusters 
FigUre 5 | Persistence of global repertoire properties over time. (a) 
Correlation in relative usage proportion of each VJ gene combination from 
samples on different days from participant AF01. Stronger correlations are in 
darker blue. (B) Change in the mean number of V gene mutations of 
sequences in the repertoire over time. (c) Change in repertoire diversity over 
time, calculated using the Shannon entropy index, with each cluster 
represented as a distinct species. (D) Change in proportion of the repertoire 
comprised by sequences of the different IgA and IgG subclasses over time. 
(e) Euclidean distances between the diversity profiles of each sample were 
calculated, used for hierarchical clustering of the samples, and visualized as a 
heatmap. The color of the heatmap indicates the similarity in the profile 
between two samples (red = high similarity, white = low similarity). The color 
bars indicate the isotype of each sample.
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were, therefore, labeled as potentially containing sequences with 
specificity toward TT and influenza, respectively. The potential 
TT and influenza-specific clusters were present in samples of at 
least one isotype from each participant, but only in small num-
bers. The mean number of potential TT-specific and influenza-
specific clusters was 1.1 and 0.5, respectively for IgA, 1.0 and 0.6 
for IgG, and 10.5 and 9.4 for IgM. Despite the low numbers, where 
they were present, potential TT and influenza-specific clusters 
comprised a greater percentage of the public compared to the 
private repertoire (Figure 7E).
DiscUssiOn
By collecting both repeat samples from a single participant as well 
as samples from multiple different participants, we have been able 
to perform in-depth assessment of both the within-individual, 
and inter-individual variation in the BCR repertoire. We show 
high reproducibility in the methods used to sample the BCR 
repertoire, and although not exhaustively sampling the entire 
repertoire at the individual B cell clone level, calculate compa-
rable global repertoire metrics, and routinely detect abundant 
clusters in repeat samples. In the absence of an immune stimulus 
given during the study, there was considerable variation in the 
BCR repertoire over time in a single individual, highlighting that 
it is a highly dynamic system that is constantly subject to immune 
stimulus and selective pressures. Nevertheless, there are certain 
features that remain steady, which enable unique identification of 
different individuals, and may be a contributing factor to genetic 
causes of variation in the immune response. Finally, we show 
that there is a small public repertoire, and that this has a distinct 
structure, and appears enriched for specificity toward commonly 
encountered antigens.
Although there is no standardized BCR repertoire sequencing 
protocol, different protocols give comparable results (45), so the 
data generated here are still informative for laboratories using 
alternate protocols. We favored use of a simple and cost-effective 
protocol, so that it could potentially be used on a large scale in 
the context of clinical trials, or for routine diagnostic tests. As 
input, we used 500,000 B cells  –  this number can normally be 
obtained from 2 to 8  ml of peripheral blood, so is a feasible 
quantity for routine sampling, including samples obtained from 
the youngest infants. To account for sequencing and PCR error 
in the dataset, a clustering-based approach was used that groups 
together related sequences. This approach is intended to just 
group together sequences arising from the same cell that only 
differ due to sequencing or PCR error; however, it is likely that 
sequences arising from clonally related cells, or cells with similar 
specificities will also be grouped together. Indeed, other labora-
tories have used similar approaches to identify what they term to 
be clones, or clonotypes (9, 46), but this could be misleading, as B 
cells from distinct clonal origins could converge toward a similar 
sequence (12). For this reason, we instead consider the clusters to 
be groups of sequences that likely have a similar antigenic speci-
ficity. Using clustering for error correction is cheaper than using 
unique molecular identifier tags (43), which require increased 
depth of sequencing and may have other associated errors (47). 
We detected a small number of clusters that had identical CDR3 
AA cluster center sequences, which were combined with different 
V and J gene segments. Such sequences could be PCR chimeras, 
or form during convergent evolution of different B cells toward 
FigUre 6 | inter-individual variation in global repertoire properties. (a) Principal component analysis of VJ segment usage in each participant. Five samples 
from participant AF01 are included, each corresponding to a sample from a different day. Differences in mean number of V gene mutations of sequences in the 
repertoire (B), repertoire diversity (calculated using the Shannon diversity index) (c), and proportion of the repertoire comprised by sequences of each IgG and IgA 
subclass (D) in each participant. For (B–D), bars show mean values ± SEM.
FigUre 7 | The public repertoire. (a) The percent of total clusters that are present in different numbers of participants, where percent = (A∩B/sum(A,B)) × 100. 
The blue number above each bar shows the absolute number that is shared. (B–D) Mean cluster size, mutation, and CDR3 AA sequence length in the clusters that 
are unique to a participant (private repertoire) compared to those that are present in at least one other participant (public repertoire). (e) Percent of clusters in the 
private and public repertoire that are annotated as having specificity toward either TT or Influenza antigens. For (B–e), mean values ± SEM are shown for the 10 
participants. Comparisons performed using the paired Mann-Whitney U test.
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the same antigen (12). We favor the latter explanation, as these 
clusters were only present in the IgG and IgA datasets, and not the 
IgM dataset, which is mainly comprised of naïve B cells that have 
not undergone any selection. There was a large size distribution 
of clusters ranging from those just containing a single sequence 
(0.001% of the total sequenced repertoire) to 19,662 sequences 
(nearly 20% of the repertoire). This could in part be due to 
different PCR amplification efficiencies of different templates, 
the presence of different numbers of clonally related cells from 
which sequences are being grouped together, or different RNA 
quantities in different B cell subsets. Larger clusters are, therefore, 
more likely to represent plasma cells (which have a large amount 
of RNA), or proliferating cells (of which there will be multiple 
similar cells).
Obtaining both PCR and biological replicates allowed us to 
assess the adequacy of our sequencing depth for representing 
the true diversity of the 500,000 B cells in the sample, and the 
adequacy of our sampling depth for representing the true diver-
sity of total B cells in a human. Sequencing depth and sampling 
depth are related in that there is no point collecting a large sample 
if sequencing depth is insufficient to capture the diversity of the 
sample. Under-sequencing results in a loss of information, whilst 
over-sequencing represents an unnecessary cost and increases 
the number of erroneous sequences in the dataset. Rarefaction 
analysis indicated that whilst we are not capturing the entire 
diversity of the 500,000 B cells, we are reliably capturing the most 
abundant clusters. So, for most applications, our sequencing 
depth should be sufficient, but for rare cluster identification, a 
greater sequencing depth would be recommended, especially for 
the IgM population, which forms the greatest proportion of the 
total B cells. For isotype-specific BCR repertoire sequencing from 
a pool of total B cells, in order to reliably sequence 90% of cells 
in the sample, we recommend aiming for at least a 0.5:1 ratio of 
sequences to cells for IgA and IgG, and a 1:1 ratio of sequences to 
cells for IgM populations. Using the biological replicates, the esti-
mates of total IgG repertoire size we determined were steady over 
time, and in line with previous studies (43, 48). Considering just 
the abundant clusters, estimates varied by nearly a factor of 10 at 
the different times, indicating that the repertoire of these clusters 
is more likely to be affected by immune fluctuations. It is worth 
emphasizing though, that our repertoire size estimates should 
be considered a lower bound for the total number of circulating 
clones. Sequences from similar clones may be clustered together, 
and the data violate the capture-recapture analysis assumption of 
equal abundance of all clusters, which will cause the size estimates 
to be deflated.
At day 7, the dramatic changes in mean mutation levels 
(increase), diversity (decrease), and isotype subclass usage 
are indicative of potential B cell activation (4). We, therefore, 
hypothesize that these changes were due to a subclinical immune 
activation in this participant at day 7. In addition, the abundant 
repertoire had the smallest estimated repertoire size at day 7, 
potentially due to a restriction toward more limited antigenic 
specificity. Despite their reduction in number, the abundant 
clusters were large and mutated, so likely composed of rapidly 
proliferating B cells (49). The day 7 suspected immune stimulus 
highlights how dynamic the repertoire is over time, so for studies 
of the BCR repertoire following immune stimulation, it must, 
therefore, be considered that there could be natural stimulations 
of the repertoire that could affect the results. Further evidence for 
this comes from studying the differences between participants, 
where one had high mutation, and low repertoire diversity, indica-
tive of immune stimulation in this participant as well. A larger 
study of more participants at multiple timepoints is necessary to 
determine exactly how common such immune stimulations are 
in normal healthy individuals, and how long they tend to last. In 
addition, further exploration of the optimal statistical approach 
for measuring BCR repertoire diversity is required (50). We used 
three different single diversity measures that have previously 
been applied to BCR repertoire studies (8, 35). These all gave 
similar results, and were adequate for detecting the change at day 
7. However, it has been reported that the use of different single 
diversity measures could give different results when comparing 
BCR repertoires, depending on the weight they give to abundant 
vs. rare species (36). For this reason, we also used the diversity 
profile method for comparing repertoires as suggested by Greiff 
et al. (36), which was also able to distinguish the day 7 samples 
from the other days.
Despite the day 7 changes in the repertoire, the proportion 
of usage of different VJ gene combinations remained steady 
over time in a single individual, compared to the relatively large 
differences between individuals. As VJ usage, therefore, appears 
unique to an individual, and certain V genes are preferentially 
used in a protective response to certain antigens (51, 52), it 
could potentially be a cause of variation in disease and vaccine 
responses between individuals. As well as VJ usage frequency, V 
gene genotype is also unique for each individual in this study, 
and as certain V gene alleles may have different binding abilities 
to certain antigens (53), this may also affect disease and vaccine 
response. Although isotype subclass usage, mutation and diver-
sity are more affected by immune stimulation, they also display 
considerable inter-individual variation. We hypothesized that 
one cause of this could be the different ages of the individuals in 
the study, as it has previously been observed that the repertoire in 
more elderly participants is less diverse and more mutated (9, 35). 
We also saw a decrease in diversity, and increase in mutation with 
age, although this was not a statistically significant finding. Most 
striking, however, was a significant decrease in IgG2 levels with 
age, coinciding with an increase in IgG1 and IgG3. Such an obser-
vation is of potential importance, as the different IgG subclasses 
have different activities in different antigenic contexts (54), and 
change in their relative abundance could be a contributing factor 
to immunosenescence (55). For example, IgG2 is important for 
mounting immune responses against polysaccharide-encapsu-
lated pathogens (such as Neisseria meningitides and Streptococcus 
pneumonia) (56). Such responses are reduced in older individuals 
(57), so this could be due to decreased IgG2 levels.
It appears that when different individuals are exposed to a 
common antigenic stimulus, there is a degree of similarity in 
the response (a public repertoire) at the BCR sequence level, 
and that this could be used to identify antigen-specific BCR 
sequences (4, 11, 17, 21). However, here we also observe the 
presence of a public repertoire in the absence of any common 
immune stimulation. The presence of such a public repertoire 
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could have three possible causes: laboratory contamination of 
different samples, random overlap by chance, or historical com-
mon antigenic stimuli. Laboratory work was conducted under 
stringent conditions to minimize cross-sample contamination, 
and there are no clusters shared across all samples, making 
this an unlikely contributor to the public repertoire. If sharing 
was due to chance, it is expected that the public and private 
repertoires would have similar properties, but this is not the 
case. The public IgG repertoire comprises larger, more mutated 
clusters, with shorter CDR3s than the private repertoire; this 
is consistent with these clusters arising from more differenti-
ated B cell subsets (4). In addition, considering the presumed 
antigenic specificity of the clusters, a greater proportion of the 
public repertoire comprised presumed TT or influenza-specific 
clusters compared to the private repertoire. These are antigens 
to which all participants in the study are likely to have been 
exposed through either vaccination or infection, and thus 
provide support for using public repertoire analysis for identi-
fication of antigen-specific clusters following common antigen 
stimulation. However, it must be considered that this technique 
could then also enrich for sequences specific to antigens that 
are commonly encountered by the population. The public rep-
ertoire in the IgM dataset is approximately three times larger 
than that of the IgG or IgA datasets. This may be due to the 
presence of natural IgM antibodies, which target conserved 
microbial determinants and autoantigens (58); the most abun-
dant of these is anti-gal, which constitutes ~1% of all human 
antibodies (59). This could explain why the public repertoire 
is less mutated than the private repertoire for IgM sequences, 
while the converse is true for IgG sequences. Unfortunately, to 
our knowledge there are currently no large sequence datasets of 
natural antibodies available to search in our dataset to confirm 
this hypothesis.
To summarize, we present a robust BCR repertoire sequencing 
method, and demonstrate that a sample of 500,000 B cells, and 
sequencing depth of 100,000 sequences per B cell isotype should 
be sufficient for most applications. The BCR repertoire varies 
substantially within a single individual over time, and between 
multiple different individuals. Assessing the complete range of 
such variation would benefit from further characterization in 
larger study cohorts. Nevertheless, we show certain conserved 
features of the repertoire within individuals that could be predic-
tive of immune function. Finally, we investigated the public rep-
ertoire, and show that this is likely to be enriched for sequences 
with specificity toward antigens commonly encountered by the 
population.
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